✦ LIBER ✦

Final results of a phase II study of bevacizumab plus docetaxel for the first-line treatment of metastatic breast cancer (TORI-B01)

✍ Scribed by S. Hurvitz; H.J. Allen; R.L. Moroose; D. Chan; C. Hagenstad; S.H. Applebaum; G. Patel; E.H. Hu; D.J. Slamon; F. Kabbinavar

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II Trial of Docetaxel With Bevac

✍ Sara A. Hurvitz; Heather J. Allen; Rebecca L. Moroose; David Chan; Christopher H 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 598 KB

A multicenter phase I–II study of doceta

✍ Tryfonidis, K.; Boukovinas, I.; Xenidis, N.; Christophyllakis, C.; Papakotoulas, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 348 KB

Docetaxel/Gemcitabine Administered Every

✍ Amadeu Pelegrí; Lourdes Calvo; Antonio Antón; José I. Mayordomo; Jesús Florián; 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 107 KB

Biomarker results from the AVADO phase 3

✍ Miles, D W; de Haas, S L; Dirix, L Y; Romieu, G; Chan, A; Pivot, X; Tomczak, P; 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 366 KB

Phase II Multicenter Study of Docetaxel

✍ Schwartzberg, Lee S.; Badarinath, Suprith; Keaton, Mark R.; Childs, Barrett H. 📂 Article 📅 2014 🏛 CIG Media Group, LP. 🌐 English ⚖ 451 KB

Gemcitabine plus docetaxel administered

✍ Amadeu Pelegrı́; Lourdes Calvo; José I Mayordomo; Jesús Florián; Santiago Vázque 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 81 KB